Nancy Krunic

617 total citations
9 papers, 427 citations indexed

About

Nancy Krunic is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Nancy Krunic has authored 9 papers receiving a total of 427 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Hematology, 3 papers in Molecular Biology and 3 papers in Genetics. Recurrent topics in Nancy Krunic's work include Chronic Myeloid Leukemia Treatments (4 papers), Nitric Oxide and Endothelin Effects (3 papers) and Chronic Lymphocytic Leukemia Research (3 papers). Nancy Krunic is often cited by papers focused on Chronic Myeloid Leukemia Treatments (4 papers), Nitric Oxide and Endothelin Effects (3 papers) and Chronic Lymphocytic Leukemia Research (3 papers). Nancy Krunic collaborates with scholars based in United States, Canada and Poland. Nancy Krunic's co-authors include Susanne Saußele, Norbert Gattermann, Valentín García‐Gutiérrez, Andreas Hochhaus, Jerald P. Radich, David M. Ross, Philipp D. le Coutre, Tamás Masszi, Jesper Stentoft and Véronique Bédoucha and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Annals of the New York Academy of Sciences.

In The Last Decade

Nancy Krunic

9 papers receiving 419 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nancy Krunic United States 8 317 265 159 84 64 9 427
Karima Yacouben France 7 240 0.8× 136 0.5× 104 0.7× 42 0.5× 37 0.6× 12 341
J.G. Fuzibet France 9 155 0.5× 61 0.2× 25 0.2× 65 0.8× 50 0.8× 37 341
Achille Aouba France 10 61 0.2× 36 0.1× 52 0.3× 26 0.3× 38 0.6× 17 248
Axel Nolting Germany 9 57 0.2× 65 0.2× 26 0.2× 153 1.8× 40 0.6× 27 357
Gastaut Ja France 10 164 0.5× 61 0.2× 11 0.1× 55 0.7× 54 0.8× 38 315
Fred Goldman United States 10 138 0.4× 60 0.2× 10 0.1× 36 0.4× 48 0.8× 15 372
Jeffrey S. Wisch United States 6 227 0.7× 46 0.2× 23 0.1× 41 0.5× 110 1.7× 9 468
Monica Maccaferri Italy 7 53 0.2× 76 0.3× 31 0.2× 31 0.4× 20 0.3× 17 160
Ahmad Malluh United States 10 131 0.4× 34 0.1× 15 0.1× 73 0.9× 25 0.4× 11 341
Masaaki� Hotta Japan 11 132 0.4× 50 0.2× 12 0.1× 66 0.8× 57 0.9× 40 277

Countries citing papers authored by Nancy Krunic

Since Specialization
Citations

This map shows the geographic impact of Nancy Krunic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nancy Krunic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nancy Krunic more than expected).

Fields of papers citing papers by Nancy Krunic

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nancy Krunic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nancy Krunic. The network helps show where Nancy Krunic may publish in the future.

Co-authorship network of co-authors of Nancy Krunic

This figure shows the co-authorship network connecting the top 25 collaborators of Nancy Krunic. A scholar is included among the top collaborators of Nancy Krunic based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nancy Krunic. Nancy Krunic is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Ross, David M., Tamás Masszi, María Teresa Gómez‐Casares, et al.. (2018). Durable treatment-free remission in patients with chronic myeloid leukemia in chronic phase following frontline nilotinib: 96-week update of the ENESTfreedom study. Journal of Cancer Research and Clinical Oncology. 144(5). 945–954. 104 indexed citations
2.
Hochhaus, Andreas, Tamás Masszi, Francis J. Giles, et al.. (2017). Treatment-free remission following frontline nilotinib in patients with chronic myeloid leukemia in chronic phase: results from the ENESTfreedom study. Leukemia. 31(7). 1525–1531. 203 indexed citations
3.
Hochhaus, Andreas, Tamás Masszi, Francis J. Giles, et al.. (2016). Treatment-free remission (TFR) in patients (pts) with chronic myeloid leukemia in chronic phase (CML-CP) treated with frontline nilotinib: Results from the ENESTFreedom study.. Journal of Clinical Oncology. 34(15_suppl). 7001–7001. 8 indexed citations
4.
Hughes, Timothy P., Carla Boquimpani, Naoto Takahashi, et al.. (2016). Treatment-Free Remission in Patients with Chronic Myeloid Leukemia in Chronic Phase According to Reasons for Switching from Imatinib to Nilotinib: Subgroup Analysis from ENESTop. Blood. 128(22). 792–792. 16 indexed citations
5.
Krunic, Nancy, et al.. (2011). Advances in the diagnosis of respiratory tract infections: role of the Luminex xTAG respiratory viral panel. Annals of the New York Academy of Sciences. 1222(1). 6–13. 14 indexed citations
6.
Krunic, Nancy, et al.. (2007). xTAG™ RVP assay: analytical and clinical performance. Journal of Clinical Virology. 40. S39–S46. 60 indexed citations
7.
Krunic, Nancy, S. Lee Adamson, & Flavio Coceani. (2000). Differential uptake and catabolism of prostaglandin (PG)E2 versus PGF2α in the sheep choroid plexus during development. Developmental Brain Research. 119(1). 11–19. 5 indexed citations
8.
Krunic, Nancy, S. Lee Adamson, Cameron Ackerley, Richard T. Okita, & Flavio Coceani. (2000). Perinatal changes in choroidal 15-hydroxyprostaglandin dehydrogenase: implications for prostaglandin removal from brain. Developmental Brain Research. 121(2). 145–155. 7 indexed citations
9.
Krunic, Nancy, S. Lee Adamson, Isis Bishai, & Flavio Coceani. (1997). Prostaglandin uptake and catabolism by the choroid plexus during development in sheep. Developmental Brain Research. 100(1). 82–89. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026